article thumbnail

STAT+: Study finds heavier reliance on nurse practitioners, physician assistants after private equity takeovers

STAT News

A new study suggests physician practices acquired by private equity rely more heavily on advanced practice providers like nurse practitioners and physician assistants and experience higher churn compared with their non-private equity owned peers.

Nurses 105
article thumbnail

Google Launches AI-Based Dermatology Assist Tool

XTalks

Google has developed an AI-powered dermatology assist tool designed to detect conditions of the skin, hair and nails based on phone images taken by the user. The tool allows users to identify dermatologic issues such as a rash on the arm or nail discoloration using a phone camera. Development of the AI Dermatology Health Tool.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Even Winter Carries Skin Cancer Risks for College Students

The Pharma Data

24, 2020 – Researchers from two universities in Utah have a warning for students planning to hit the slopes or play in the snow without sunscreen: You could greatly increase your risk of skin cancer. A survey of students by Brigham Young University College of Nursing in Provo found that only 9% use sunscreen. THURSDAY, Dec.

Nurses 52
article thumbnail

Clinical Catch-Up: January 18-22 | BioSpace

The Pharma Data

It will be run through the NIAID-supported Infectious Diseases Clinical Research Consortium (IDCRC), with support from the Bill & Melinda Gates Foundation. The drug was well tolerated and demonstrated clinically meaningful improvement in the Dermatology Life Quality Index (DLQI) and Patient-Oriented Eczema Measure IPOEM).

Trials 52
article thumbnail

CheckMate -577, a Phase 3 Trial Evaluating Opdivo (nivolumab) as Adjuvant Therapy for Patients with Resected Esophageal or Gastroesophageal Junction Cancer, Meets Primary Endpoint of Disease-Free Survival

The Pharma Data

Bristol Myers Squibb: Advancing Cancer Research. The goal of our cancer research is to increase patients’ quality of life, long-term survival and make cure a possibility. Immune-Mediated Skin and Dermatologic Adverse Reactions. While GEJ cancer has a lower prevalence than gastric cancer, it continues to rise.

Trials 52
article thumbnail

CheckMate -649, a Phase 3 Trial Evaluating Opdivo (nivolumab) Plus Chemotherapy vs. Chemotherapy, Meets Primary Endpoints Demonstrating Superior Overall Survival and Progression-Free Survival in First-Line Treatment of Gastric and Esophageal Cancers

The Pharma Data

Bristol Myers Squibb: Advancing Cancer Research. The goal of our cancer research is to increase patients’ quality of life, long-term survival and make cure a possibility. Immune-Mediated Skin and Dermatologic Adverse Reactions. At Bristol Myers Squibb, patients are at the center of everything we do. Serious Adverse Reactions.

Trials 52